Abstract
Obesity affects over 600 million people worldwide and, despite recent therapeutic advance in the field, projections estimate a continuous increase of its prevalence over the next decade. In this context, the identification of new targets could improve therapeutic strategies and contribute to revert the current epidemiological scenario. G protein-coupled receptors (GPCRs) are the targets f…